Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.
Russo
C L
CL
Glader
B E
BE
Israel
R J
RJ
Galasso
F
F
D000293:Adolescent; D000380:Agranulocytosis / Q000188:drug therapy*; D000741:Anemia, Aplastic / Q000150:complications; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D015774:Ganciclovir / Q000009:adverse effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007642:Keratosis / Q000151:congenital*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000188:drug therapy*; D010198:Pancytopenia / Q000150:complications; D013577:Syndrome
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D015774:Ganciclovir